Diagnostic methods and treatment options for focal cortical dysplasia

Epilepsia

Volumn 56, Issue 11, 2015, Pages 1669-1686

  Guerrini, Renzo ^a,b   Duchowny, Michael ^c   Jayakar, Prasanna ^c   Krsek, Pavel ^d   Kahane, Philippe ^e,f   Tassi, Laura ^g   Melani, Federico ^a   Polster, Tilman ^h   Andre, Véronique M ⁱ   Cepeda, Carlos ^j   Krueger, Darcy A ^k   Cross, J Helen ^l,m   Spreafico, Roberto ⁿ   Cosottini, Mirco ^o   Gotman, Jean ^p   Chassoux, Francine ^q   Ryvlin, Philippe ^r,s   Bartolomei, Fabrice ^t,u,v,w   Bernasconi, Andrea ^x   Stefan, Hermann ^y   Miller, Ian ^c   Devaux, Bertrand ^q   Najm, Imad ^z   Giordano, Flavio ^a   Vonck, Kristl ^aa   Barba, Carmen ^a   Blumcke, Ingmar ^y   more..

^a UNIVERSITY OF FLORENCE   (Italy)

^b DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^c MIAMI CHILDREN'S HOSPITAL   (United States)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^e UNIV GRENOBLE ALPES   (France)

^f HÔPITAL MICHALLON   (France)

^g OSPEDALE NIGUARDA CA GRANDA   (Italy)

^h EPILEPSY CENTER BETHEL   (Germany)

ⁱ UCB PHARMA   (Belgium)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^l GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^m YOUNG EPILEPSY   (United Kingdom)

ⁿ DEPARTMENT OF NEUROSURGERY   (Italy)

^o UNIVERSITY OF PISA   (Italy)

^p MCGILL UNIVERSITY   (Canada)

^q CENTRE HOSPITALIER SAINTE ANNE   (France)

^r LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^s LYON NEUROSCIENCE RESEARCH CENTER   (France)

^t AIX MARSEILLE UNIVERSITÉ   (France)

^u AIX MARSEILLE UNIVERSITY   (France)

^v TIMONE HOSPITAL   (France)

^w Henri Gastaut Hospital   (France)

^x MCGILL UNIVERSITY   (Canada)

^y UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^z LERNER RESEARCH INSTITUTE   (United States)

^aa GHENT UNIVERSITY   (Belgium)

more..

Author keywords

Drug resistance; EEG; Epilepsy surgery; Epileptogenesis; Focal cortical dysplasia; MRI; PET

Indexed keywords

4 AMINOBUTYRIC ACID; FLUORODEOXYGLUCOSE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; NEUROPEPTIDE; ANTICONVULSIVE AGENT;

ARTICLE; CLINICAL FEATURE; CORTICAL DYSPLASIA; ELECTRODE IMPLANTATION; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HIGH FREQUENCY OSCILLATION; HUMAN; IMAGE PROCESSING; KETOGENIC DIET; MAGNETOENCEPHALOGRAPHY; MULTIMODAL IMAGING; NERVE STIMULATION; NERVOUS SYSTEM INFLAMMATION; NEUROPHYSIOLOGY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT PLANNING; VAGUS NERVE STIMULATION; DRUG RESISTANT EPILEPSY; MALFORMATIONS OF CORTICAL DEVELOPMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; TREATMENT OUTCOME;

ANTICONVULSANTS; DRUG RESISTANT EPILEPSY; ELECTROENCEPHALOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MALFORMATIONS OF CORTICAL DEVELOPMENT; TREATMENT OUTCOME;

EID: 84946481859     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.13200     Document Type: Article

References (162)

1. Barkovich AJ, Guerrini R, Kuzniecky RI, et al., A developmental and genetic classification for malformations of cortical development: update 2012. Brain 2012; 135: 1348-1369.
2. Palmini A, Holthausen H,. Focal malformations of cortical development: a most relevant etiology of epilepsy in children. Handb Clin Neurol 2013; 111: 549-565.
3. Muhlebner A, Coras R, Kobow K, et al., Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol 2012; 123: 259-272.
4. Blumcke I, Thom M, Aronica E, et al., The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011; 52: 158-174.
5. Taylor DC, Falconer MA, Bruton CJ, et al., Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971; 34: 369-387.
6. Tassi L, Colombo N, Garbelli R, et al., Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 2002; 125: 1719-1732.
7. Tassi L, Garbelli R, Colombo N, et al., Electroclinical, MRI and surgical outcomes in 100 epileptic patients with type II FCD. Epileptic Disord 2012; 14: 257-266.
8. Urbach H, Scheffler B, Heinrichsmeier T, et al., Focal cortical dysplasia of Taylor's balloon cell type: a clinicopathological entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia 2002; 43: 33-40.
9. Fauser S, Huppertz HJ, Bast T, et al., Clinical characteristics in focal cortical dysplasia: a retrospective evaluation in a series of 120 patients. Brain 2006; 129: 1907-1916.
10. Chassoux F, Landre E, Mellerio C, et al., Type II focal cortical dysplasia: electro-clinical phenotype and surgical outcome related to imaging. Epilepsia 2012; 53: 349-358.
11. Chassoux F, Rodrigo S, Semah F, et al., FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology 2010; 75: 2168-2175.
12. Chamberlain WA, Cohen ML, Gyure KA, et al., Interobserver and intraobserver reproducibility in focal cortical dysplasia (malformations of cortical development). Epilepsia 2009; 50: 2593-2598.
13. Coras R, de Boer OJ, Armstrong D, et al., Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasias. Epilepsia 2012; 53: 1341-1348.
14. Sarnat H, Flores-Sarnat L, Crino P, et al., Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis. Folia Neuropathol 2012; 50: 330-345.
15. Crino PB, Nathanson KL, Henske EP,. The tuberous sclerosis complex. N Engl J Med 2006; 355: 1345-1356.
16. Crino PB,. mTOR: a pathogenic signaling pathway in developmental brain malformations. Trends Mol Med 2011; 17: 734-742.
17. Conti V, Pantaleo M, Barba C, et al., Focal dysplasia of the cerebral cortex and infantile spasms associated with somatic 1q21.1-q44 duplication including the AKT3 gene. Clin Genet 2015; 88: 241-247.
18. Scheffer IE, Heron SE, Regan BM, et al., Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol 2014; 75: 782-787.
19. D'Gama AM, Geng Y, Couto JA, et al., Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia. Ann Neurol 2015; 77: 720-725.
20. Lim JS, Kim WI, Kang HC, et al., Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med 2015; 21: 395-400.
21. Baulac S, Ishida S, Marsan E, et al., Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann Neurol 2015; 77: 675-683.
22. Nakashima M, Saitsu H, Takei N, et al., Somatic mutations in the MTOR gene cause focal cortical dysplasia type IIb. Ann Neurol 2015; 78: 375-386.
23. Strauss KA, Puffenberger EG, Huentelman MJ, et al., Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med 2006; 354: 1370-1377.
24. Barba C, Parrini E, Coras R, et al., Co-occurring malformations of cortical development and SCN1A gene mutations. Epilepsia 2014; 55: 1009-1019.
25. Weckhuysen S, Holmgren P, Hendrickx R, et al., Reduction of seizure frequency after epilepsy surgery in a patient with STXBP1 encephalopathy and clinical description of six novel mutation carriers. Epilepsia 2013; 54: e74-e80.
26. Chen J, Tsai V, Parker WE, et al., Detection of human papillomavirus in human focal cortical dysplasia type IIB. Ann Neurol 2012; 72: 881-892.
27. Coras R, Korn K, Bien CG, et al., No evidence for human papillomavirus infection in focal cortical dysplasia IIb. Ann Neurol 2015; 77: 312-319.
28. Palmini A, Najm I, Avanzini G, et al., Terminology and classification of the cortical dysplasias. Neurology 2004; 62 (Suppl. 3): S2-S8.
29. Tassi L, Garbelli R, Colombo N, et al., Type I focal cortical dysplasia: surgical outcome is related to histopathology. Epileptic Disord 2010; 12: 181-191.
30. Fauser S, Schulze-Bonhage A,. Epileptogenicity of cortical dysplasia in temporal lobe dual pathology: an electrophysiological study with invasive recordings. Brain 2006; 129: 82-95.
31. Blumcke I, Coras R, Miyata H, et al., Defining clinico-neuropathological subtypes of mesial temporal lobe epilepsy with hippocampal sclerosis. Brain Pathol 2012; 22: 402-411.
32. Blumcke I, Pieper T, Pauli E, et al., A distinct variant of focal cortical dysplasia type I characterised by magnetic resonance imaging and neuropathological examination in children with severe epilepsies. Epileptic Disord 2010; 12: 172-180.
33. Hildebrandt M, Pieper T, Winkler P, et al., Neuropathological spectrum of cortical dysplasia in children with severe focal epilepsies. Acta Neuropathol 2005; 110: 1-11.
34. Garbelli R, Milesi G, Medici V, et al., Blurring in patients with temporal lobe epilepsy: clinical, high-field imaging and ultrastructural study. Brain 2012; 135: 2337-2349.
35. Barkovich AJ, Kuzniecky RI, Bollen AW, et al., Focal transmantle dysplasia: a specific malformation of cortical development. Neurology 1997; 49: 1148-1152.
36. Colombo N, Salamon N, Raybaud C, et al., Imaging of malformations of cortical development. Epileptic Disord 2009; 11: 194-205.
37. Mellerio C, Labeyrie MA, Chassoux F, et al., Optimizing MR imaging detection of type 2 focal cortical dysplasia: best criteria for clinical practice. AJNR Am J Neuroradiol 2012; 33: 1932-1938.
38. Mellerio C, Labeyrie MA, Chassoux F, et al., 3T MRI improves the detection of transmantle sign in type 2 focal cortical dysplasia. Epilepsia 2014; 55: 117-122.
39. Najm IM, Tassi L, Sarnat HB, et al., Epilepsies associated with focal cortical dysplasias (FCDs). Acta Neuropathol 2014; 128: 5-19.
40. Spencer S, Huh L,. Outcomes of epilepsy surgery in adults and children. Lancet Neurol 2008; 7: 525-537.
41. Krsek P, Jahodova A, Maton B, et al., Low-grade focal cortical dysplasia is associated with prenatal and perinatal brain injury. Epilepsia 2010; 51: 2440-2448.
42. Kim YH, Kang HC, Kim DS, et al., Neuroimaging in identifying focal cortical dysplasia and prognostic factors in pediatric and adolescent epilepsy surgery. Epilepsia 2011; 52: 722-727.
43. Fauser S, Essang C, Altenmüller DM, et al., Is there evidence for clinical differences related to the new classification of temporal lobe cortical dysplasia? Epilepsia 2013; 54: 909-917.
44. Johnson AM, Sugo E, Barreto D, et al., Clinicopathological associations in temporal lobe epilepsy patients utilising the current ILAE focal cortical dysplasia classification. Epilepsy Res 2014; 108: 1345-1351.
45. Krsek P, Pieper T, Karlmeier A, et al., Different presurgical characteristics and seizure outcomes in children with focal cortical dysplasia type I or II. Epilepsia 2009; 50: 125-137.
46. Janszky J, Ebner A, Kruse B, et al., Functional organization of the brain with malformations of cortical development. Ann Neurol 2003; 53: 759-767.
47. Guerrini R, Barba C,. Malformations of cortical development and aberrant cortical networks: epileptogenesis and functional organization. J Clin Neurophysiol 2010; 27: 372-379.
48. Marusic P, Najm IM, Ying Z, et al., Focal cortical dysplasias in eloquent cortex: functional characteristics and correlation with MRI and histopathologic changes. Epilepsia 2002; 43: 27-32.
49. Jayakar P, Duchowny M, Resnick TJ,. Subdural monitoring in the evaluation of children for epilepsy surgery. J Child Neurol 1994; 9 (Suppl. 2): 61-66.
50. Raymond AA, Fish DR,. EEG features of focal malformations of cortical development. J Clin Neurophysiol 1996; 13: 495-506.
51. Thiebaut de Schotten M, Kinkingnéhun S, Delmaire C, et al., Visualization of disconnection syndromes in humans. Cortex 2008; 44: 1097-1103.
52. Duchowny M, Jayakar P, Levin B,. Aberrant neural circuits in malformations of cortical development and focal epilepsy. Neurology 2000; 55: 423-428.
53. Jayakar P, Gaillard WD, Tripathi M, et al., Diagnostic test utilization in evaluation for resective epilepsy surgery in children. Recommendations on behalf of the Task Force for Paediatric Epilepsy Surgery and the Diagnostic Commission of the ILAE. Epilepsia 2014; 55: 507-518.
54. Wagner J, Urbach H, Niehusmann P, et al., Focal cortical dysplasia type IIb: completeness of cortical, not subcortical, resection is necessary for seizure freedom. Epilepsia 2011; 52: 1418-1424.
55. Guénot M, Isnard J, Catenoix H, et al., SEEG-guided RF-thermocoagulation of epileptic foci: a therapeutic alternative for drug-resistant non-operable partial epilepsies. Adv Tech Stand Neurosurg 2011; 36: 61-78.
56. Cossu M, Fuschillo D, Cardinale F, et al., Stereo-EEG-guided radio-frequency thermocoagulations of epileptogenic grey-matter nodular heterotopy. J Neurol Neurosurg Psychiatry 2014; 85: 611-617.
57. Willie JT, Laxpati NG, Drane DL, et al., Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Neurosurgery 2014; 74: 569-584.
58. Palmini A, Gambardella A, Andermann F, et al., Operative strategies for patients with cortical dysplastic lesions and intractable epilepsy. Epilepsia 1994; 35 (Suppl. 6): S57-S71.
59. Gambardella A, Palmini A, Andermann F, et al., Usefulness of focal rhythmic discharges on scalp EEG of patients with focal cortical dysplasia and intractable epilepsy. Electroencephalogr Clin Neurophysiol 1996; 98: 243-249.
60. Holthausen H, Teixeira VA, Tuxhorn I, et al., Epilepsy surgery in children and adolescents with focal cortical dysplasia. In, Tuxhorn I, Holthausen H, Boenigk H, (Eds) Paediatric epilepsy syndromes and their surgical treatment. London: John Libbey & Company Ltd; 1997: 199-215.
61. Palmini A, Gambardella A, Andermann F, et al., Intrinsic epileptogenicity of human dysplastic cortex as suggested by corticography and surgical results. Ann Neurol 1995; 37: 476-487.
62. Boonyapisit K, Najm I, Klem G, et al., Epileptogenicity of focal malformations due to abnormal cortical development: direct electrocorticographic histopathologic correlations. Epilepsia 2003; 44: 69-76.
63. Chassoux F, Devaux B, Landré E, et al., Stereoelectroencephalography in Focal Cortical Dysplasia: a three-dimensional approach to delineating the dysplastic cortex. Brain 2000; 123: 1733-1751.
64. Francione S, Nobili L, Cardinale F, et al., Intra-lesional stereo-EEG activity in Taylor 's focal cortical dysplasia. Epileptic Disord 2003; 5 (Suppl. 2): S105-S114.
65. Aubert S, Wendling F, Regis J, et al., Local and remote epileptogenicity in focal cortical dysplasias and neurodevelopmental tumours. Brain 2009; 132: 3072-3086.
66. Menezes Cordeiro I, von Ellenrieder N, Zazubovits N, et al., Sleep influences the intracerebral EEG pattern of focal cortical dysplasia. Epilepsy Res 2015 113: 132-139.
67. Perucca P, Dubeau F, Gotman J,. Intracranial electroencephalographic seizure-onset patterns: effect of underlying pathology. Brain 2014; 137: 183-196.
68. Varotto G, Tassi L, Franceschetti S, et al., Epileptogenic networks of type II focal cortical dysplasia: a stereo-EEG study. NeuroImage 2012; 61: 591-598.
69. Cepeda C, André VM, Flores-Hernández J, et al., Pediatric cortical dysplasia: correlations between neuroimaging, electrophysiology and location of cytomegalic neurons and balloon cells and glutamate/GABA synaptic circuits. Dev Neurosci 2005; 27: 59-76.
70. González-Martínez JA, Ying Z, Prayson R, et al., Glutamate clearance mechanisms in resected cortical dysplasia. J Neurosurg 2011; 114: 1195-1202.
71. Buccoliero AM, Barba C, Giordano F, et al., Expression of glutamine synthetase in balloon cells: a basis of their antiepileptic role? Clin Neuropathol 2015; 34: 83-88.
72. Serino D, Freri E, Ragona F, et al., Focal seizures versus epileptic spasms in children with focal cortical dysplasia and epilepsy onset in the first year. Epilepsy Res 2015; 109: 203-209.
73. Gaily EK, Shewmon DA, Chugani HT, et al., Asymmetric and asynchronous infantile spasms. Epilepsia 1995; 36: 873-882.
74. Fusco L, Vigevano F,. Ictal clinical electroencephalographic findings of spasms in West syndrome. Epilepsia 1993; 34: 671-678.
75. de la Vaissière S, Milh M, Scavarda D, et al., Cortical involvement in focal epilepsies with epileptic spasms. Epilepsy Res 2014; 108: 1572-1580.
76. Pittau F, Dubeau F, Gotman J,. Contribution of EEG/fMRI to the definition of the epileptic focus. Neurology 2012; 78: 1479-1487.
77. Moeller F, Tyvaert L, Nguyen DK, et al., EEG-fMRI: adding to standard evaluations of patients with nonlesional frontal lobe epilepsy. Neurology 2009; 73: 2023-2030.
78. Thornton R, Vulliemoz S, Rodionov R, et al., Epileptic networks in focal cortical dysplasia revealed using electroencephalography-functional magnetic resonance imaging. Ann Neurol 2011; 70: 822-837.
79. An D, Fahoum F, Hall J, et al., Electroencephalography/functional magnetic resonance imaging responses help predict surgical outcome in focal epilepsy. Epilepsia 2013; 54: 2184-2194.
80. Fahoum F, Zelmann R, Tyvaert L, et al., Epileptic discharges affect the Default Mode Network-fMRI and intracerebral EEG evidence. PLoS ONE 2013; 8: e68038.
81. Jacobs J, Levan P, Châtillon CE, et al., High frequency oscillations in intracranial EEGs mark epileptogenicity rather than lesion type. Brain 2009; 132: 1022-1037.
82. Zijlmans M, Jacobs J, Zelmann R, et al., High frequency oscillations mirror disease activity in patients with epilepsy. Neurology 2009; 72: 979-986.
83. Jacobs J, Zijlmans M, Zelmann R, et al., High-frequency electroencephalographic oscillations correlate with outcome of epilepsy surgery. Ann Neurol 2010; 67: 209-220.
84. Ferrari-Marinho T, Perucca P, Mok K, et al., Pathological substrates of focal epilepsy influence the generation of high-frequency oscillations. Epilepsia 2015; 56: 592-598.
85. Kerber K, LeVan P, Dümpelmann M, et al., High frequency oscillations mirror disease activity in patients with focal cortical dysplasia. Epilepsia 2013; 54: 1428-1436.
86. Stefan H, Schneider S, Abraham-Fuchs K, et al., Magnetic source localization in focal epilepsy. Multichannel magnetoencephalography correlated with magnetic resonance brain imaging. Brain 1990; 113: 1347-1359.
87. Ishibashi H, Simos PG, Wheless JW, et al., Localization of ictal and interictal bursting epileptogenic activity in focal cortical dysplasia: agreement of magnetoencephalography andelectrocorticography. Neurol Res 2002; 24: 525-530.
88. Bast T, Oezkan O, Rona S, et al., EEG and MEG source analysis of single and averaged interictal spikes reveals intrinsic epileptogenicity in focal cortical dysplasia. Epilepsia 2004; 45: 621-631.
89. Kim DW, Kim S, Park SH, et al., Comparison of MRI features andsurgical outcome among the subtypes of focal cortical dysplasia. Seizure 2012; 21: 789-794.
90. Schwartzkroin PA, Wenzel HJ,. Are developmental dysplastic lesions epileptogenic? Epilepsia 2012; 53 (Suppl. 1): 35-44.
91. Heers M, Rampp S, Stefan H, et al., MEG-based identification of the epileptogenic zone in occult peri-insular epilepsy. Seizure 2012; 21: 128-133.
92. Wang ZI, Jin K, Kakisaka Y, et al., Imag(in)ing seizure propagation: MEG-guided interpretation of epileptic activity from a deep source. Hum Brain Mapp 2012; 33: 2797-2801.
93. Mu J, Rampp S, Carrette E, et al., Clinical relevance of source location in frontal lobe epilepsy and prediction of postoperative long-term outcome. Seizure 2014; 23: 553-559.
94. Winston GP, Micallef C, Kendell BE, et al., The value of repeat neuroimaging for epilepsy at a tertiary referral centre: 16 years of experience. Epilepsy Res 2013; 105: 349-355.
95. Moser E, Stahlberg F, Ladd ME, et al., 7-T MR-from research to clinical applications? NMR Biomed 2012; 25: 695-716.
96. Duyn JH, van Gelderen P, Li TQ, et al., High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci USA 2007; 104: 11796-11801.
97. De Ciantis A, Barkovich AJ, Cosottini M, et al., AJNR Am J Neuroradiol 2015; 36: 309-316.
98. Costagli M, Kelley DA, Symms MR, et al., Tissue Border Enhancement by inversion recovery MRI at 7.0 Tesla. Neuroradiology 2014; 56: 517-523.
99. Salamon N, Kung J, Shaw SJ, et al., FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology 2008; 71: 1594-1601.
100. Chassoux F,. Stereo-EEG: the Sainte-Anne experience in focal cortical dysplasias. Epileptic Disord 2003; 5 (Suppl. 2): 95-103.
101. Chugani H,. Infantile spasms. Curr Opin Neurol 1995; 8: 139-144.
102. Vinters HV, De Rosa MJ, Farrell MA,. Neuropathologic study of resected cerebral tissue from patients with infantile spasms. Epilepsia 1993; 34: 772-779.
103. O'Brien TJ, So EL, Cascino GD, et al., Subtraction SPECT coregistered to MRI in focal malformations of cortical development: localization of the epileptogenic zone in epilepsy surgery candidates. Epilepsia 2004; 45: 367-376.
104. Krsek P, Kudr M, Jahodova A, et al., Localizing value of ictal SPECT is comparable to MRI and EEG in children with focal cortical dysplasia. Epilepsia 2013; 54: 351-358.
105. Duyn JH,. The future of ultra-high field MRI and fMRI for study of the human brain. NeuroImage 2012; 62: 1241-1248.
106. Bernasconi A, Antel SB, Collins DL, et al., Texture analysis and morphological processing of magnetic resonance imaging assist detection of focal cortical dysplasia in extra-temporal partial epilepsy. Ann Neurol 2001; 49: 770-775.
107. Bernasconi A, Bernasconi N, Bernhardt BC, et al., Advances in MRI for 'cryptogenic' epilepsies. Nat Rev Neurol 2011; 7: 99-108.
108. Cross JH, Jayakar P, Nordli D, et al., Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia 2006; 47: 952-959.
109. Gaillard WD, Cross JH, Duncan JS, et al., Epilepsy imaging study guideline criteria: commentary on diagnostic testing study guidelines and practice parameters. Epilepsia 2011; 52: 1750-1756.
110. Jayakar P, Dunoyer C, Dean P, et al., Epilepsy surgery in patients with normal or nonfocal MRI scans: integrative strategies offer long-term seizure relief. Epilepsia 2008; 49: 758-764.
111. Semah F, Picot MC, Adam C, et al., Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998; 51: 1256-1262.
112. Stephen LJ, Kwan P, Brodie MJ,. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia 2001; 42: 357-362.
113. Liimatainen SP, Raitanen JA, Ylinen AM, et al., The benefit of active drug trials is dependent on aetiology in refractory focal epilepsy. J Neurol Neurosurg Psychiatry 2008; 79: 808-812.
114. Cepeda C, Hurst RS, Flores-Hernandez J, et al., Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 2003; 72: 472-486.
115. Andre VM, Cepeda C, Vinters HV, et al., Pyramidal cell responses to gamma-aminobutyric acid differ in type I and type II cortical dysplasia. J Neurosci Res 2008; 86: 3151-3162.
116. Andre VM, Cepeda C, Vinters HV, et al., Interneurons, GABAA currents, and subunit composition of the GABAA receptor in type I and type II cortical dysplasia. Epilepsia 2010; 51 (Suppl. 3): 166-170.
117. Nardou R, Yamamoto S, Chazal G, et al., Neuronal chloride accumulation and excitatory GABA underlie aggravation of neonatal epileptiform activities by phenobarbital. Brain 2011; 134: 987-1002.
118. Cepeda C, André VM, Levine MS, et al., Epileptogenesis in pediatric cortical dysplasia: the dysmature cerebral developmental hypothesis. Epilepsy Behav 2006; 9: 219-235.
119. Dzhala VI, Talos DM, Sdrulla DA, et al., NKCC1 transporter facilitates seizures in the developing brain. Nat Med 2005; 11: 1205-1213.
120. Puskarjov M, Kahle KT, Ruusuvuori E, et al., Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures. Epilepsia 2014; 55: 806-818.
121. Pressler RM, Boylan GB, Marlow N, et al., Neonatal seizure treatment with Medication Off-patent (NEMO) consortium. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial. Lancet Neurol 2015; 14: 469-477.
122. Cepeda C, André VM, Hauptman JS, et al., Differential sensitivity of cortical neurons to 4-aminopyridine and rapamycin in diverse forms of pediatric epilepsy. Soc Neurosci 2010; 36: 657.9. Abstract.
123. D'Antuono M, Louvel J, Kohling R, et al., GABAA receptor-dependent synchronization leads to ictogenesis in the human dysplastic cortex. Brain 2004; 127: 1626-1640.
124. Aronica E, Becker AJ, Spreafico R,. Malformations of cortical development. Brain Pathol 2012; 22: 380-401.
125. Galanopoulou AS, Gorter JA, Cepeda C,. Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target. Epilepsia 2012; 53: 1119-1130.
126. Zeng LH, Xu L, Gutmann DH, et al., Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 2008; 63: 444-453.
127. Krueger DA, Care MM, Holland K, et al., Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 2010; 363: 1801-1811.
128. Krueger DA, Wilfong AA, Holland-Bouley K, et al., Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 2013; 74: 679-687.
129. Guo W, Zhang CQ, Shu HF, et al., Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex. J Mol Neurosci 2013; 50: 7-13.
130. Zeng LH, Rensing NR, Wong M,. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci 2009; 29: 6964-6972.
131. Russo E, Citraro R, Donato G, et al., mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy. Neuropharmacology 2013; 69: 25-36.
132. Neal EG, Chaffe HM, Edwards N, et al., The ketogenic diet in the treatment of epilepsy in children: a randomised, controlled trial (NCT00564915). Lancet Neurol 2008; 7: 500-506.
133. Neal EG, Chaffe HM, Schwartz RH, et al., A randomised trial of classical and medium chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 2009; 50: 1109-1117.
134. Sharma S, Sankhyan N, Gulati S, et al., Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomised controlled trial. Epilepsia 2013; 54: 481-486.
135. Kobow K, Kaspi A, Harikrishnan KN, et al., Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropathol 2013; 126: 741-756.
136. Fell R, Fraga MF,. Epigenetics and the environment: emerging patterns and implicaitons. Nat Rev Genet 2012; 13: 97-109.
137. Thammongol S, Vears DF, Bicknell-Royle J, et al., Efficacy of the ketogenic diet: which epilepsies respond? Epilepsia 2012; 53: e55-e59.
138. Jung DE, Kang HC, Kim HD,. Long-term outcome of the ketogenic diet for intractable childhood epilepsy with focal cortical malformation of cortical development. Pediatrics 2008; 122: e330-e333.
139. Aronica E, Crino PB,. Inflammation in epilepsy: clinical observations. Epilepsia 2011; 52 (Suppl. 3): 26-32.
140. Iyer A, Zurolo E, Spliet WGM, et al., Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 2010; 51: 1763-1773.
141. Weichhart T, Saemann MD,. The multiple facets of mTOR in immunity. Trends Immunol 2009; 30: 218-226.
142. Vezzani A, Aronica E, Mazarati A, et al., Epilepsy and brain inflammation. Exp Neurol 2013; 244: 11-21.
143. Ying Z, Babb TL, Mikuni N, et al., Selective coexpression of NMDAR2A/B and NMDAR1 subunit proteins in dysplastic neurons of human epileptic cortex. Exp Neurol 1999; 159: 409-418.
144. Möddel G, Jacobson B, Ying Z, et al., The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia. Brain Res 2005; 1046: 10-23.
145. Zhu S, Paoletti P,. Allosteric modulators of NMDA receptors: multiple sites and mechanisms. Curr Opin Pharmacol 2015; 20: 14-23.
146. Yu S, Li S, Shu H, et al., Upregulated expression of voltage-gated sodium channel Nav1.3 in cortical lesions of patients with focal cortical dysplasia type IIb. NeuroReport 2012; 23: 407-411.
147. Marnet D, Devaux B, Chassoux F, et al., Surgical resection of focal cortical dysplasias in the central region. Neurochirurgie 2008; 54: 399-408.
148. Benifla M, Sala F Jr, Jane J, et al., Neurosurgical management of intractable rolandic epilepsy in children: role of resection in eloquent cortex. Clinical article. J Neurosurg Pediatr 2009; 4: 199-216.
149. Hauptman JS, Mathern GW,. Surgical treatment of epilepsy associated with cortical dysplasia: 2012 update. Epilepsia 2012; 53 (Suppl. 4): 98-104.
150. Sahin M, Menache CC, Holmes GL, et al., Outcome of severe refractory status epilepticus in children. Epilepsia 2001; 42: 1461-1467.
151. Vendrame M, Loddenkemper T,. Surgical treatment of refractory status epilepticus in children: candidate selection and outcome. Semin Pediatr Neurol 2010; 17: 182-189.
152. Gowda S, Salazar F, Bingaman WE, et al., Surgery for catastrophic epilepsy in infants 6 months of age and younger. J Neurosurg Pediatr 2010; 5: 603-607.
153. Lerner JT, Salamon N, Hauptman JS, et al., Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 2009; 50: 1310-1335.
154. Ben-Menachem E,. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002; 1: 477-482.
155. Sprengers M, Vonck K, Carrette E, et al., Deep brain and cortical stimulation for epilepsy. Cochrane Database Syst Rev 2014; 6: 1-90.
156. Janszky J, Hoppe M, Behne F, et al., Vagus nerve stimulation: predictors of seizure freedom. J Neurol Neurosurg Psychiatry 2005; 76: 384-389.
157. Alexopoulos AV, Kotagal P, Loddenkemper T, et al., Long-term results with VNS in children with pharmacoresistent epilepsy. Seizure 2006; 15: 491-503.
158. Ghaemi K, Elsharkawy AE, Schulz R, et al., Vagus nerve stimulation: outcome and predictors of seizure freedom in long-term follow-up. Seizure 2010; 19: 264-268.
159. Fregni F, Otachi PT, Do Valle A, et al., A randomized clinical trial of repetitive transcranial magnetic stimulation in patients with refractory epilepsy. Ann Neurol 2006; 60: 447-455.
160. Sun W, Mao W, Meng X, et al., Low frequency repetitive TMS for the treatment of refractory partial epilepsy: a controlled clinical study. Epilepsia 2012; 53: 1782-1789.
161. Benabid AL, Minotti L, Koudsié A, et al., Antiepileptic effect of high-frequency stimulation of the subthalamic nucleus (corpus luysi) in a case of medically intractable epilepsy caused by focal dysplasia: a 30th month follow-up: technical case report. Neurosurgery 2002; 50: 1385-1392.
162. Pouyatos B, Serduc R, Chipaux M, et al., Synchrotron X-ray interlaced microbeams suppress paroxysmal oscillations in neuronal networks initiating generalized epilepsy. Neurobiol Dis 2013; 51: 152-160.